Phase 2 Type 2 Diabetes Trial A separate Phase 2 trial evaluated retatrutide in adults with type 2 diabetes
Lead Time, Inventory & Logistics Typical lead time for Retatrutide 40 mg Pen with Cartridge Box (R&D Only) is 46 weeks
has divulged glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, prediabetes, metabolic syndrome, stroke, metabolic dysfunction-associated steatohepatitis, cardiovascular and renal disorders, among others
These interventions predominantly intersect at the NOmTORAMPK signaling axis, which represents a pivotal regulatory network that harmonizes muscle metabolism, vascular functionality, and cellular energy equilibrium
doi:10.2337/db14-0263 78
Kadoglou NP, Fotiadis G, Kapelouzou A, Kostakis A, Liapis CD, Vrabas IS